Prelude Therapeutics, Inc. (PRLD)
3.75
-0.14
(-3.60%)
USD |
NASDAQ |
Oct 12, 16:00
3.75
0.00 (0.00%)
After-Hours: 17:14
Prelude Therapeutics Free Cash Flow (Quarterly) : -15.57M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.57M |
| March 31, 2026 | -21.68M |
| December 31, 2025 | 23.12M |
| September 30, 2025 | -19.12M |
| June 30, 2025 | -26.10M |
| March 31, 2025 | -34.28M |
| December 31, 2024 | -20.80M |
| September 30, 2024 | -27.36M |
| June 30, 2024 | -23.42M |
| March 31, 2024 | -32.08M |
| December 31, 2023 | -24.71M |
| September 30, 2023 | -26.27M |
| June 30, 2023 | -28.65M |
| March 31, 2023 | -30.94M |
| Date | Value |
|---|---|
| December 31, 2022 | -23.32M |
| September 30, 2022 | -21.36M |
| June 30, 2022 | -19.23M |
| March 31, 2022 | -22.85M |
| December 31, 2021 | -26.00M |
| September 30, 2021 | -22.43M |
| June 30, 2021 | -20.29M |
| March 31, 2021 | -17.13M |
| December 31, 2020 | -15.18M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -10.00M |
| December 31, 2019 | -8.668M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Q32 Bio, Inc. | -3.075M |
| Intellia Therapeutics, Inc. | -84.92M |
| Twist Bioscience Corp. | -8.648M |
| Beam Therapeutics, Inc. | -68.51M |
| Revolution Medicines, Inc. | -389.60M |